Comments
Loading...
Monte Rosa Therapeutics (NASDAQ:GLUE) Stock, Earnings Estimates, EPS, And Revenue
Monte Rosa Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 13
EPS Estimate
$0.110
Quarterly Revenue Estimate
$51.19M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$14.97M
Analyze the earnings history of Monte Rosa Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Monte Rosa Therapeutics (GLUE) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-07 | $-0.29 | $-0.49 | 40.8 % |
| Q2 | 2024-08-08 | $-0.43 | $-0.54 | 20.4 % |
| Q1 | 2024-05-09 | $-0.53 | $-0.57 | 7.02 % |
| Q4 | 2024-03-14 | $-0.58 | $-0.33 | -75.8 % |
Monte Rosa Therapeutics (GLUE) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-07 | $9.22M | $2.62M | 251.8 % |
| Q2 | 2024-08-08 | $4.70M | $1.35M | 247.8 % |
| Q1 | 2024-05-09 | $1.06M | $1.40M | -24.0 % |
| Q4 | 2024-03-14 | $0 | $15.15M | -100.0 % |
FAQ
When is Monte Rosa Therapeutics (NASDAQ:GLUE) reporting earnings?
Monte Rosa Therapeutics (GLUE) is scheduled to report earnings on March 13, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
What were the latest earnings per share (EPS) for Monte Rosa Therapeutics (NASDAQ:GLUE)?
The Actual EPS was $-0.29, which beat the estimate of $-0.49.
What were Monte Rosa Therapeutics’s (NASDAQ:GLUE) revenues?
The Actual Revenue was $9.2M, which beat the estimate of $2.6M.
Browse earnings estimates, EPS, and revenue on all stocks.